Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States

To address influenza B lineage mismatch and co-circulation, several quadrivalent inactivated influenza vaccines (IIV4s) containing two type A strains and both type B lineages have recently been approved in the United States. Currently available trivalent inactivated vaccines (IIV3s) or trivalent liv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Clements, Karen M, Meier, Genevieve, McGarry, Lisa J, Pruttivarasin, Narin, Misurski, Derek A
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2014
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896600/
https://ncbi.nlm.nih.gov/pubmed/24609063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28221
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires